The Supreme Court on Wednesday ruled for the FDA in its crackdown on sweet-flavored vaping products following a surge in teen ...

In 2004, rofecoxib (Vioxx), widely promoted as a pain reliever, was found to increase the risk of serious heart problems. In ...

Some raise concerns about disruption in services ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...

Device company Prometheus, maker of rectal therapeutic systems and probes, will pay $550,000 to settle allegations that it ...

More than 350,000 noncitizen healthcare workers in the U.S. may be at risk of deportation as part of the Trump administration ...

During the American Public Health Association (APHA) panel " Navigating the Vaccine Debate ," keynote speaker Paul Offit, MD, ...

Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...

Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...

Receiving the live-attenuated zoster vaccine (Zostavax) reduced the probability of a new dementia diagnosis by 3.5 percentage ...

According to the latest 42-page list from HHS of grants terminated under the Trump administration's Department of Government Efficiency (DOGE) purges, almost $9 billion that was expected to be ...

The Supreme Court appeared divided Wednesday over whether states should be able to cut off Medicaid funding to Planned ...